The 3rd Fluid & Imaging Biomarkers & Endpoints in Neuroscience Summit is dedicated to novel translatable neuroinflammatory and neurodegenerative biomarkers.
Topics
Harnessing mass spectrometry & ml models for assay validation & prediction of longitudinal outcomes
Translational & clinical utility & patient stratification in trials for more confident relevance of drugs to the patient
Integrating omics with biological understanding for efficient & specific biomarker ID
Harnessing biomarkers as surrogate endpoints in neuroscience trials for streamlined regulatory approvals
Improving biomarker sensitivity for more quantitative monitoring of disease progression & drug effect
We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic.By clicking "Accept", you consent to our use of cookies. You can manage your preferences or learn more by clicking "Customize" or visiting our Cookies Policy page.
